US Stock Insider Trading | Stryker disclosed 20 insider transactions on February 6

K-LinePoet · 2026-03-07T03:58:03+00:00

On February 6, 2026, Stryker Corporation disclosed 20 insider trading transactions. Director Lobo Kevin bought 207,000 shares on that day, while Director STRYKER RONDA E sold shares multiple times between February 4 and 5, with a total transaction amount exceeding $100 million. Stryker is a global leader in medical technology.

K-LinePoet

2026-03-07 03:58:03

Abstract generation in progress

On February 6, 2026, Stryker (SYK) disclosed 20 insider transactions. Director Kevin Lobo purchased 207,000 shares.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	30,100	362.69	10,905,000
February 6, 2026	Director	Ronda E. Stryker	February 5, 2026	Sell	61,200	363.34	222,361,000
February 6, 2026	Director	Ronda E. Stryker	February 5, 2026	Sell	68,700	362.42	248,936,000
February 6, 2026	Director	Ronda E. Stryker	February 5, 2026	Sell	4,239	361.50	1,532,400
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	14,400	358.51	5,175,800
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	40,400	360.41	14,547,400
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	25,200	361.39	9,114,100
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	14,700	359.48	5,274,700
February 6, 2026	Director	Ronda E. Stryker	February 5, 2026	Sell	34,600	364.29	12,606,800
February 6, 2026	Director	Ronda E. Stryker	February 4, 2026	Sell	20,400	363.50	7,413,500

【Company Information】

Stryker Corporation was founded in 1946 in Michigan, originating from a company established by Dr. Homer in 1941. It is one of the world’s leading medical technology companies, committed to making healthcare better alongside its customers. The company offers innovative products and services in orthopedics, medical and surgical, neurotechnology, and spine, aiming to improve outcomes for patients and hospitals.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes